CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Phone905-673-8501
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees4
Next Earnings DateN/A
OptionableNot Optionable
CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions
What is CardioGenics' stock symbol?
CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."
Has CardioGenics been receiving favorable news coverage?
News articles about CGNH stock have been trending extremely negative on Friday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CardioGenics earned a media sentiment score of -4.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for CardioGenics.
Who are some of CardioGenics' key competitors?
Some companies that are related to CardioGenics include Accelerize (ACLZ), China Techfaith Wireless Comm. Tech. (CNTF), Dale Jarrett Racing Adventure (TVMD), LiveWorld (LVWD), Invictus Financial (IVFZF), Hydrophi Technologies Group (HPTG), Nsav (NSAV), MoneyOnMobile (MOMT), Prism Technologies Group (PRZM), InterCloud Systems (ICLD), Spindle (SPDL), CAPITA GRP/ADR (CTAGY), Coupon Express (CPXP), Live Current Media (LIVC) and Local (LOCMQ).
What other stocks do shareholders of CardioGenics own?
Who are CardioGenics' key executives?
CardioGenics' management team includes the folowing people:
- Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc., Chief Exec. Officer and Director (Age 61)
- Mr. James A. Essex CA, MBA, Chief Financial Officer (Age 70)
- Ms. Linda J. Stering F.Inst.L.C.O., Sec. & Director (Age 58)
How do I buy shares of CardioGenics?
Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is CardioGenics' stock price today?
One share of CGNH stock can currently be purchased for approximately $0.01.
How big of a company is CardioGenics?
What is CardioGenics' official website?
How can I contact CardioGenics?
CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected]
MarketBeat Community Rating for CardioGenics (OTCMKTS CGNH)
MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe CGNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
